Ukraine's leader gets vaccine shot to dispel public doubts
Ukrainian servicemen wait to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Ukrainian servicemen wait to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:02 AM EST
In this handout photo provided by the Ukrainian Presidential Press Office, Ukrainian President Volodymyr Zelensky receives a dose of the AstraZeneca vaccine, marketed under the name CoviShield, as he visits the war-hit Luhansk region, eastern Ukraine, Tuesday, March 2, 2021. (Ukrainian Presidential Press Office via AP)

In this handout photo provided by the Ukrainian Presidential Press Office, Ukrainian President Volodymyr Zelensky receives a dose of the AstraZeneca vaccine, marketed under the name CoviShield, as he visits the war-hit Luhansk region, eastern Ukraine, Tuesday, March 2, 2021. (Ukrainian Presidential Press Office via AP)

Mar. 02, 2021 08:20 AM EST
A Ukrainian serviceman waits to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A Ukrainian serviceman waits to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:04 AM EST
A medic prepares to administer a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield, to a Ukrainian serviceman at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A medic prepares to administer a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield, to a Ukrainian serviceman at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:02 AM EST
A Ukrainian serviceman receives a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A Ukrainian serviceman receives a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 10:32 AM EST
A Ukrainian serviceman receives a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A Ukrainian serviceman receives a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:01 AM EST
Ukrainian servicemen stand in line as they wait to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Ukrainian servicemen stand in line as they wait to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:31 AM EST
A medic prepares to administer a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield, to a Ukrainian serviceman at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A medic prepares to administer a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield, to a Ukrainian serviceman at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:01 AM EST
A Ukrainian serviceman gets ready to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A Ukrainian serviceman gets ready to receive a dose of the AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:03 AM EST
A Ukrainian serviceman receives a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

A Ukrainian serviceman receives a dose of an AstraZeneca COVID-19 vaccine marketed under the name CoviShield at a military base in Kramatorsk, Ukraine, Tuesday, March 2, 2021. Ukraine plans to vaccinate 14.4 million people this year, or about 35% of its 41 million people. (AP Photo/Evgeniy Maloletka)

Mar. 02, 2021 11:01 AM EST